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Abstract
Background
The quality of health care after myocardial infarction 
(MI) may be lacking; in particular, guidelines for nonphar-
macologic interventions (cardiac rehabilitation, smoking 
cessation) may receive insufficient priority. We identified 
gaps between secondary prevention guidelines and ambu-
latory care received by Medicaid enrollees after an MI.
Methods
MI survivors were selected by using 2004 Washington 
State Medicaid administrative claims. Deidentified data 
were abstracted for hospitalizations, ambulatory care, 
and prescriptions for 365 days after the MI. Cox regres-
sion analysis compared utilization of guideline-directed 
secondary prevention strategies with death and recurrent 
hospitalization.
Results
The sample size was 372. Fifty patients died during 
the year after the MI, and 144 were rehospitalized. Only 
2 patients attended a cardiac rehabilitation program. 
Tobacco cessation counseling was associated with a 66% 
reduction in death, but only 72.6% of smokers were coun-
seled. Less than half (45.4%) of patients saw a primary 
care provider within 90 days of their MI, and 7.5% never 
contacted a health care provider. Receiving regular pri-
mary care was associated with a decreased risk for death 
(hazard ratio, 0.91; 95% confidence interval, 0.84-0.97, P 
< .01). A protective trend was associated with care by a 
cardiologist, but only 21.5% received specialist care.
Conclusion
Analysis of Medicaid claims data suggests rates of 
secondary prevention are less than optimal. To improve 
survival and reduce rehospitalization after an MI, policy 
changes (tobacco cessation benefits, expansion of rehabili-
tation programs), health care capacity (training, referral 
patterns, and coordination of care), and improvements to 
access (removing barriers, increasing facilities, targeting 
minority populations) could be implemented.
Introduction
Cardiovascular disease is the leading cause of death for 
men and women in the United States. In 2004, approxi-
mately 7.9 million Americans had a myocardial infarction 
(MI); of these, 452,327 or 5.7% died acutely (1). Recurrent 
MIs are largely preventable by aggressive risk factor reduc-
tion, including pharmacologic and lifestyle recommenda-
tions. One-year survival improved from 74.7% with no 
care to 95.7% with optimal care, including pharmacologic 
and lifestyle recommendations (2). Many organizations, 
such as the American Heart Association (AHA), American 
College of Cardiology (ACC), and European Society of 
Cardiology, have published guidelines that specify the evi-
dence-based components of optimal secondary prevention, 
and programs such as AHA’s Get With the Guidelines 
help implement those guidelines (3-6). However, evidence 
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suggests discharge planning and outpatient secondary 
prevention are not improving as rapidly as processes of 
optimal inpatient care, despite guidelines (7).
In particular, guidelines associated with nonpharmaco-
logic interventions (cardiac rehabilitation, smoking ces-
sation, physical activity, weight reduction) may receive 
insufficient priority. Recent results from facilities imple-
menting Get With the Guidelines quality improvement 
programs show nonpharmacologic interventions are rec-
ommended 26% to 54% of the time, compared with drug 
recommendations that were made 86% to 93% of the time 
(8). Many studies describe aspects of adhering to phar-
macologic regimens for secondary prevention, but few 
have documented rates of lifestyle management after MI 
(9-12). To our knowledge, none has done so in a Medicaid 
population. The need for nonpharmacologic strategies is 
well documented (13). In addition to secondary preven-
tion of MI, lifestyle modifications reduce the risk for many 
chronic diseases and have been prioritized as a common 
agenda by the AHA, American Diabetes Association, and 
American Cancer Society (14).
In addition, many studies demonstrate lower quality of 
care and poorer MI outcomes in patients of lower socio-
economic status (SES) or minority ethnicities (15-17). 
Disparities between the care of whites and minorities has 
been documented in all aspects of care, from the rate at 
which interventional procedures are offered to ambulatory 
screening for cardiovascular risk factors (18-20). In fact, 
the rate of MI-related deaths showed the same small dif-
ferences at 1 year: 39.7% for blacks and 37.6% for whites 
(P = .001) (21). Minorities are disproportionately repre-
sented in lower SES strata; compared with lower-SES 
patients, more affluent and better-educated patients were 
more likely to receive cardiac rehabilitation (43.9% vs 
25.6%, P < .001) or to be seen by a cardiologist (56.7% vs 
47.8%, P < .001) (22). Some of these disparities may be 
attributable to underlying differences in access to care 
(privately insured vs Medicare/Medicaid); however, the 
ratio of minorities enrolled in Medicaid is substantially 
higher than in the general population.
For these reasons, and because Medicare/Medicaid 
programs are publicly funded, we observed ambulatory 
health care utilization, with emphasis on nonpharmaco-
logic interventions, among Washington Medicaid enrollees 
during the year after they experienced an MI to better 
understand the characteristics and quality of care they 
received. These findings may be useful to address gaps in 
access to and utilization of secondary prevention programs 
that include nonpharmacologic strategies.
Methods
This study included all Medicaid enrollees diagnosed 
with an MI and discharged alive from an inpatient facility 
in 2004, on the basis of administrative claims data from 
the Washington State Department of Social and Health 
Services. Institutional review board approval was obtained 
from both the state of Washington and the University of 
Washington. Data consisted of deidentified recipient and 
claims information (medical and pharmacy) for Medicaid 
fee-for-service enrollees discharged from an inpatient facil-
ity with a diagnosis of MI (International Classification 
of Diseases, Ninth Revision codes 410.xx) during 2004. 
Excluded from the sample were any patients who were not 
continuously eligible for Medicaid insurance coverage for 
365 subsequent days, unless the person died while eligible. 
Of an eligible sample of 395 patients, we excluded 15 who 
did not have claims beyond the first 7 days after discharge 
and 8 who were missing data such as Medicare eligibility 
status (Figure). Most analyses are based on this sample of 
372; for analyses involving details of subsequent diagnoses 
(such as comorbidity), the completeness of the data limited 
the sample to single-eligibility Medicaid enrollees. The 
details of claims were abstracted for the initial MI hospi-
talization, any rehospitalizations, any ambulatory care, 
and any prescriptions that the patient received during the 
365 days after the MI. To create an analyzable dataset, 3 
separate data files that contained multiple lines per case 
were aggregated into single variables by using AHA/ACC 
guidelines for secondary prevention.
Nonpharmacologic risk factor reduction strategies are 
difficult to capture with claims data because of incomplete 
documentation. Consequently, we included only variables 
that were reimbursed by Medicaid and therefore most like-
ly to be accurately documented; this limited variables to 
cardiac rehabilitation and smoking cessation (23). Cardiac 
rehabilitation services were identified by Diagnosis-Related 
Group or Current Procedural Terminology (CPT) codes. 
The CPT definitions are used by the Centers for Medicare 
and Medicaid Services to reimburse for cardiac rehabilita-
tion and usually represent the method that other payers, 
including the Department of Social and Health Services, 
would likely use. Smoking cessation was defined by using 
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both International Classification of Diseases diagnoses 
and supplemental classification codes and CPT codes for 
basic or intensive counseling. We did not identify prescrip-
tion smoking cessation aids because Medicaid reimburse-
ment limits this to buproprion, which may be prescribed 
for other indications.
Ascertaining comorbidity was difficult because of vari-
able levels of detail among claims; hospitalizations could 
include up to 9 concomitant diagnoses, ambulatory vis-
its had up to 4 diagnoses, and claims for dually eligible 
enrollees variably contained between 0 and 4 diagnoses. 
Because of this variation, a count of comorbid conditions 
was unreliable. We excluded symptom-based and self-
limiting diagnoses, and after ranking by frequency, we 
selected diagnoses associated with chronic diseases: heart 
failure, cancer, renal failure, or diabetes. These were 
included as a covariate in models in an attempt to adjust 
for severity of illness. Because of the imperfect nature of 
this definition and because of incomplete ascertainment 
of comorbidity in the dually eligible Medicare/Medicaid 
enrollees, analyses adjusted for comorbidity were run only 
on the Medicaid-only split sample.
Data were analyzed by using SPSS version 11 (SPSS, 
Inc, Chicago, Illinois). To characterize care received by 
Washington Medicaid enrollees who were hospitalized 
for MI in 2004, descriptive statistics were generated for 
demographic characteristics, Medicaid/Medicare eligibility 
status, and comorbidity. We compared Medicaid-only with 
Medicare/Medicaid enrollees by using t tests and χ2 analy-
ses. To investigate associations between guideline-directed 
secondary prevention strategies and recurrent hospitaliza-
tion or death within the 12 months after MI, we developed 
Cox proportional hazard models that used time to death 
or time to first rehospitalization as dependent variables. 
The analyses were run both unadjusted and adjusted for 
significant variables: age, sex, ethnicity, and comorbidity.
Results
Enrollees were predominantly white urban residents; a 
slightly larger percentage were men, and the average age 
was 64 years (Table 1). Women were significantly older 
than men when they had their MI (67 years for women, 
60 years for men, P < .001). The patients represented 2 
broad categories in terms of Medicaid eligibility. Slightly 
less than half (47.3%) had Medicaid coverage only; the 
remainder (52.7%) had coverage under both Medicare 
and Medicaid. As would be expected, patients with both 
Medicare and Medicaid coverage were significantly older 
than those who had only Medicaid coverage. Single- 
eligibility patients were significantly more likely to be non-
white. The 2 groups did not differ significantly in terms of 
residence.
For each patient, we obtained details from claim records 
regarding the quantity and type of medical care they 
obtained in the year after their MI. In total, 38.7% 
of patients were rehospitalized within a year; single- 
eligibility patients had significantly fewer rehospitaliza-
tions than did Medicaid/Medicare patients, although this 
finding was expected because dually eligible patients were 
older. Of the 372 patients, 50 died during the year after 
their MI (Table 1).
More than 80% of the patients had diagnoses related 
to the circulatory system, including 30% with subsequent 
MI, 14% with other acute and subacute forms of ischemic 
heart disease, 25% with previous MI, and 48% with other 
forms of chronic ischemic heart disease (up to 9 diagnoses 
were documented per hospitalization). Half of the patients 
had diagnoses involving endocrine, nutritional, and meta-
bolic diseases, including diabetes (29%), disorders of lipid 
metabolism (25%), and obesity (10%). Sixteen percent 
had tobacco-use disorder diagnoses. Only 2 patients par-
ticipated in a cardiac rehabilitation program, even though 
rehabilitation is covered by Medicaid. Smoking cessation 
Figure. Sample selection of 372 Washington State Medicaid or Medicare/
Medicaid recipients who had a diagnosis of MI in 2004. Abbreviations: MI, 
myocardial infarction; ICD-9, International Classification of Diseases, Ninth 
Revision. 
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counseling was more widely offered; 73% of smokers 
received smoking cessation counseling at least once. 
Counseling was associated with a 66% mortality reduction 
(P = .08) in the crude Cox regression model. The effect of 
cardiac rehabilitation on outcomes of interest could not 
be tested because of the small number of patients who 
received it, although data from large clinical trials have 
demonstrated substantial benefit (24,25).
Having a primary care visit during the first 90 days after 
an MI was associated with a lower risk of rehospitalization 
(Table 2); however, the opposite effect was seen with risk 
of death (Table 3). When adjusted for demographic char-
acteristics and comorbidity, the association with risk of 
death was attenuated and no longer significant. A total of 
28 patients (7.5%) had no follow-up care at all during the 
year after their MI, although each had at least 1 claim for 
medications or laboratory services.
Discussion
Reducing risk factors
Adherence to cardiovascular disease prevention guide-
lines improves survival, reduces recurrent events and 
the need for interventional procedures, and improves the 
quality of life. The magnitude of risk reduction seen in 
the literature ranges from a 12% reduction in mortality 
associated with aspirin use, to a 25% mortality reduction 
over 2 years with participation in a cardiac rehabilitation 
program, to an estimate of nearly 50% fewer deaths from 
coronary artery disease over 2 years if guidelines were 
followed in all cases (26). Attempts to quantify the benefit 
of rehabilitation beyond adherence to drug regimens esti-
mated a 52% reduction in reinfarction (27).
Rates of cardiac rehabilitation in the United States are 
generally low despite these benefits. Estimates of national 
utilization rates have ranged from 9% to 34% (28,29). Data 
specific to the state of Washington, where the study sam-
ple resided, are limited to the patient self-reported mea-
sures collected in the Behavioral Risk Factor Surveillance 
System Survey; 28% of Washingtonians who had a heart 
attack or stroke reported participating in a rehabilitation 
program (30). Our findings suggest a lower rate of reha-
bilitation among Medicaid enrollees. This rate may be low 
for several reasons. As noted previously, rates of provider 
recommendations for nonpharmacologic interventions are 
low; few Medicaid enrollees may have been referred to 
cardiac rehabilitation. Additionally, minorities are over-
represented in the Medicaid population; our findings may 
reflect the lower quality of care and poorer MI outcomes 
typically seen among patients of lower socioeconomic sta-
tus or minority ethnicities (15-17).
Tobacco cessation is a priority according to secondary 
prevention guidelines, although rates of tobacco use in 
our sample were below the national average. Nationally, 
29% of Medicaid enrollees smoke (31). Among Washington 
Medicaid enrollees, the rate of documented tobacco use 
was 19%. Of course, this statistic is subject to limitations 
in coding; that is, providers are more likely to document 
use if they are planning to counsel the patient about ces-
sation. Claims data cannot capture instances in which 
smoking status was not obtained. However, we found a 
significant association between tobacco cessation advice 
and survival. During hospitalization for MI, smokers are 
generally offered nicotine patches. However, after dis-
charge, this prescription is not routinely continued because 
nicotine patches are not covered by many insurance plans, 
including Medicaid. Simple changes in discharge planning 
and benefits structure could ensure that MI survivors who 
quit smoking in the hospital remain tobacco-free after dis-
charge by using aids such as nicotine patches.
Health care utilization
Although secondary prevention guidelines do not specify 
an optimal schedule of outpatient management, reestab-
lishing prompt contact with a primary care provider is con-
sidered essential to continuity of care. Cardiology specialty 
care may be appropriate for most patients after an MI, 
especially if a stent was placed or if the patient underwent 
coronary bypass surgery or another invasive procedure. 
Our findings concerning the positive effect of primary care 
are limited by the information available in the dataset, 
but they suggest a contribution to outcomes that has also 
been seen in other studies (32). We saw a reduced adjusted 
hazard ratio associated with prompt primary care that lost 
significance when adjusted for comorbidity. This finding 
is most likely because primary care providers usually see 
patients with more comorbidities (33). Some of the reduced 
risk may be associated with primary care providers’ cor-
rection of medication regimens that were incomplete at 
discharge (34).
The role of specialty care is clearer; cardiologists make 
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more referrals to cardiac rehabilitation programs, follow 
guidelines more closely, and their patients have better 
survival rates overall (32,33,35), although the survival 
benefit associated with cardiology care (as opposed to care 
delivered by primary care providers) disappears when 
adjusted for comorbidity and optimal adherence to medica-
tions (35). In our study, 21.5% of patients saw a cardiolo-
gist during the year of follow-up; among these patients, 
cardiology care showed a nonsignificant trend toward a 
survival benefit. However, our ascertainment of the sever-
ity of the initial MI was limited to diagnoses codes, and 
severity of the MI would be relevant in determining if all 
patients were in need of specialized care by a cardiologist 
or if their care could be appropriately managed by a pri-
mary care provider. Cardiology care was associated with 
an increased rehospitalization rate, which may be due 
to more admissions for nonurgent invasive procedures or 
increased severity of the MI.
Insurance status affects the quality of hospital care; 
Medicaid patients receive fewer cardiac procedures and 
have higher mortality (36-38), which may be true of the 
Medicaid population we studied as well. These results 
should be of special interest for those concerned about 
reducing disparities in medical care for low-income, ethni-
cally diverse populations.
Our analysis of nonpharmacologic strategies was limited 
to cardiac rehabilitation and smoking cessation because of 
limitations in the data in Medicaid administrative claims. 
Many other aspects of secondary prevention are impor-
tant as well. We assess the prescription of and adherence 
to medications in the same population elsewhere (39). 
However, future studies could use methods other than 
claims to better detect rates of physical activity recom-
mendation or weight management.
Secondary prevention strategies are effective, and 
trends in our data confirm that observation. Utilization 
of nonpharmacologic strategies among Medicaid enrollees 
is less than optimal, possibly for reasons related to access 
and delivery of health care. To improve survival and 
reduce recurrent hospitalization after an MI, the access 
and delivery of health care could be changed in ways 
that expand secondary prevention. These include offering 
more tobacco cessation assistance, implementing more 
cardiac rehabilitation programs, and automatically refer-
ring patients to such programs. Providers could be trained 
to refer patients to these programs more frequently, or in 
areas where formal rehabilitation programs are not easily 
accessed, lifestyle change counseling may improve out-
comes. Particular emphasis should be placed on increasing 
referrals for women and minorities, who are less frequently 
referred to rehabilitation programs (28,29). Improving the 
coordination of care between primary care providers and 
inpatient facilities may reduce the number of patients who 
never follow up with primary care. Barriers to participa-
tion in secondary prevention include many socioeconomic 
factors (28). Improvements to health care delivery should 
be undertaken in concert with community-based efforts 
to reduce barriers to utilization and increase awareness 
among patients about the benefits of secondary prevention 
in preventing future events and rehospitalizations.
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Tables
Table 1. Demographic Data for Washington State Medicaid Recipients Who Survived a Myocardial Infarction in 2004
Characteristic All Patients (N = 372)
Medicaid Only (n = 176, 
47.3%)
Medicare/Medicaid Dual 
Eligibility (n = 196, 
52.7%) P Valuea
Mean age (SD) 64 (3.) 6 (0.9) 70 (.9) <.00
Sex, n (%)
Male 9 (.3) 0 (7.4) 90 (4.9)
.03
Female 8 (48.7) 7 (42.6) 06 (4.)
Race/ethnicity, n (%)
White 20 (67.2) 04 (9.) 46 (74.)
.002b
Nonwhite  22 (32.8) 72 (40.9) 0 (2.)
  African American 27 (7.3) 24 (3.6) 3 (.)
  Asian American 29 (7.8) 4 (8.0)  (7.7)
  American Indian  (3.0) 7 (4.0) 4 (2.0)
  Hispanic 22 (.9)  (6.3)  (.6)
  Other/missing 33 (8.8) 6 (9.) 7 (8.7)
Residence, n (%)c
Metropolitan/urban 294 (79.) 44 (8.8) 0 (76.)
.24c
Micropolitan 37 (0.0)  (8.) 22 (.2)
Small town 2 (.7) 8 (4.) 3 (6.6)
Rural 9 (.) 8 (4.)  (.6)
Deceased, n (%) 0 (3.4) 4 (8.0) 36 (8.4) .003
Recurrent hospitalization, n (%) 44 (38.7) 93 (2.8)  (26.0) .00
Mean no. of rehospitalizations during the 
year (SD)
. (2.3) . (2.) 0.4 (.2) <.00
Mean no. of days to first rehospitalization 
(SD)
8.6 (02.3) 9 (96.9) 6.6 (98.6) <.00
Received an invasive procedure within the 
year, n (%)
9 (2.) 89 (0.6) 6 (3.) <.00
Comorbidity at time of MI, n (%) 3 (30.4) 04 (9.) 9 (4.6) <.00
Documented tobacco use, n (%) 7 (9.) 68 (38.6) 3 (.) <.00
 
Abbreviations: SD, standard deviation; MI, myocardial infarction. 
a Calculated by using Fisher exact t test (when cell size was small) and χ2 tests. 
b P value is for difference between whites and all other racial/ethnic minorities combined because of small numbers in each race/ethnicity category. 
c P value is for difference between urban and nonurban residence only. Rural-Urban Commuting Area codes classify US census tracts by using measures of 
population density, urbanization, and daily commuting. One Medicaid recipient in the sample was missing data on residence. 
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Table 2. Nonpharmacologic Health Care Utilization and Rehospitalization Among 372 Medicaid Recipients Who Survived a 
Myocardial Infarction, Washington State, 2004 
Aspect of Carea
Crude HR for 
Rehospitalization in 
1 Year (95% CI) P Value
Model 1, 
Adjusted HR for 
Rehospitalization in 
1 Year (95% CI)b P Value
Model 2, 
Adjusted HR for 
Rehospitalization in 
1 Year (95% CI)b P Value
Saw PCP within 90 days (n = 69) 0.69 (0.4-0.90) <.0 0.72 (0.-0.93) .0 0.7 (0.0-.3) .7
No. of PCP visits (mean, .3) .02 (.0-.03) <.0 .0 (.00-.03) <.0 .0 (.00-.03) .06
Saw cardiologist within  year (n = 80) .38 (0.97-.98) .08 .03 (0.8-.06) .2 .4 (0.74-.76) .4
No. of cardiology visits (mean, .3) .04 (.0-.06) <.0 .03 (.0-.06) <.0 .02 (.0-.0) .0
Received smoking cessation counseling 
at least once (n = 3)
. (.08-2.22) .02 .39 (0.94-2.07) .0 .20 (0.77-.87) .4
 
Abbreviations: HR, hazard ratio; CI, confidence interval; PCP, primary care provider. 
a Only 2 Medicaid recipients attended a cardiac rehabilitation program during the year after myocardial infarction. This number was too small to calculate 
HRs for rehospitalization. 
b Model  adjusted for age, sex, and race; model 2 also adjusted for comorbidity for Medicaid-only patients (n = 76). 
Table 3. Nonpharmacologic Health Care Utilization and Survival Among 372 Medicaid Recipients Who Survived a Myocardial 
Infarction, Washington State, 2004 
Aspect of Carea
Crude HR for 
Death in 1 Year 
(95% CI) P Value
Model 1, Adjusted HR 
for Death in 1 Year 
(95% CI)b P Value
Model 2, Adjusted 
HR for Death in 1 
Year (95% CI)b P Value
Saw PCP within 90 days (n = 69) 2.07 (.40-3.08) <.0 .64 (.-2.42) .0 .48 (0.49-3.89) .4
No. of PCP visits (mean, .3) 0.90 (0.8-0.9) <.0 0.92 (0.87-0.97) . 0.9 (0.84-0.97) .00
Saw cardiologist within  year (n = 80) 0.47 (0.20-.0) .08 0.7 (0.3-.8) .2 0.68 (0.8-2.3) .7
No. of cardiology visits (mean, .3) 0.99 (0.92-.06) .72 .0 (0.9-.08) .76 .0 (0.9-.08) .67
Received smoking cessation counseling at 
least once (n = 3)
0.44 (0.7-.) .08 0.89 (0.33-.8) .8 0.99 (0.29-4.43) .98
 
Abbreviations: HR, hazard ratio; CI, confidence interval; PCP, primary care provider. 
a Only 2 Medicaid recipients attended a cardiac rehabilitation program during the year after myocardial infarction. This number was too small to calculate 
HRs for death. 
b Model  adjusted for age, sex, and race; model 2 also adjusted for comorbidity for Medicaid-only patients (n = 76).
